Inflammatory Bowel Disease and Hodgkin's Lymphoma: Two New Observations

Conclusion :HL can emerge in IBD patients on immunosuppressive therapy and physicians must be aware of this possibility. EBV infection might have an intermediate role between immunosuppressive treatment and lymphoma. Those data should alert clinicians that, not only thiopurine use but also the disease itself could contribute to a higher occurrence of lymphoproliferative disorders.DisclosuresNo relevant conflicts of interest to declare.

Source: Blood - November 21, 2018 Category: Hematology Authors: Tazi Mezalek, Z., Bourkia, M., Habib Allah, S., Al Waragli, N., Bouaouad, M., Lhoussni, A., Khibri, H., Ammouri, W., Maamar, M., Harmouche, H., Adnaoui, M. Tags: 624. Hodgkin Lymphoma and T/NK Cell Lymphoma-Clinical Studies Source Type: research